Craft

Tellgen

Stock Price

¥14.8

2024-10-29

Market Capitalization

¥2.3 B

2024-10-29

Revenue

¥431.8 M

FY, 2024

Tellgen Summary

Company Summary

Overview
Tellgen is a company that manufactures and distributes IVDs. It produces tumor marker testing series, human papillomavirus and gene mutation detection, and other products.
Type
Public
Status
Active
Founded
2003
Website
http://en.tellgen.com
Sectors

Table of Contents

Tellgen Financials

Summary Financials

Revenue (Q1, 2026)
¥81.6M
Gross profit (Q1, 2026)
¥52.6M
Net income (Q1, 2026)
(¥6.3M)
Cash (Q1, 2026)
¥344.7M
EBIT (Q1, 2026)
(¥660.0K)
Enterprise value
$2.4B

Footer menu